SOX2 phosphorylation during mitosis limits genomic damage
Genes & Development · 2026
DOI: 10.1101/gad.352664.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Charles A C Williams und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Regenerative Medicine, Institute for Regeneration and Repair, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH16 …. Hauptthemen laut MEDLINE: Mitosis, SOXB1 Transcription Factors, DNA Damage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Pioneer transcription factors (TFs) such as SOX2 play critical roles in the control of stem cell identity and are dysregulated in many human cancers. For example, SOX2 regulates the self-renewal of neural stem cells (NSCs) and is typically highly expressed in glioblastoma stem cells (GSCs), where it is known to induce an immature NSC-like state. Here, we explored the regulation of SOX2 by phosphorylation during NSC division and identified an unexpected role for excessive SOX2 pioneer activity in driving mitotic damage. We found that SOX2 phosphorylation during mitosis is a key switch that prevents promiscuous chromatin binding across the genome. Without this regulatory control, excessive SOX2 in mitosis triggers chromatin opening, resulting in increased mitotic transit times and increased chromosomal damage. Therefore, elevated levels of SOX2 in cancers may have dual oncogenic roles: inducing stemness during interphase via its well-known transcriptional roles but simultaneously promoting chromosomal disruptions through unconstrained pioneer factor activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Regenerative Medicine, Institute for Regeneration and Repair, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH16 4UU, United Kingdom.
- Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH16 4UU, United Kingdom.
- MRC Laboratory of Medical Sciences, Imperial College London, London W12 0NN, United Kingdom.
- Centre for Regenerative Medicine, Institute for Regeneration and Repair, Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh EH16 4UU, United Kingdom; steven.pollard@ed.ac.uk.
ORCID-Profile: Robert Illingworth, Alex Von Kriegsheim
Förderung
- Cancer Research UK
Zitieren
APA
Williams, C. A. C., Djeghloul, D., Veland, N., Hamdan, A., Kalantzaki, M., Lo, E., Illingworth, R., Von Kriegsheim, A., Fisher, A. G., Soufi, A., & Pollard, S. M. (2026). SOX2 phosphorylation during mitosis limits genomic damage. Genes & Development. https://doi.org/10.1101/gad.352664.125
Vancouver
Williams CAC, Djeghloul D, Veland N, Hamdan A, Kalantzaki M, Lo E, et al. SOX2 phosphorylation during mitosis limits genomic damage. Genes & Development. 2026. doi:10.1101/gad.352664.125
BibTeX
@article{Williams2026,
author = {Williams, Charles A C and Djeghloul, Dounia and Veland, Nicolas and Hamdan, Alhafidz and Kalantzaki, Maria and Lo, Erika and Illingworth, Robert and Von Kriegsheim, Alex and Fisher, Amanda G and Soufi, Abdenour and Pollard, Steven M},
title = {SOX2 phosphorylation during mitosis limits genomic damage},
journal = {Genes & Development},
year = {2026},
doi = {10.1101/gad.352664.125}
}
EUVIMED